[ad_1]
For stocks, see Golden Unicorn’s authoritative, professional, timely and comprehensive analyst research report to help you take advantage of potential thematic opportunities.
Internet medical services welcome a series of favorable policies, the industry has entered a golden period of development, and actions of related concepts are expected to benefit
Original Liu Junling
Online prescription drugs are gradually liberalized.
On the morning of November 13, the Comprehensive Department of the State Administration of Medicines issued an announcement to solicit opinions on the “Measures for the supervision and administration of the sale of medicines online (Draft for comments)”. The “Reviews” first mentioned the relevant conditions for online prescription drug sales, and Qualified pharmaceutical retail companies can display prescription information to the public. Conditional online prescription drugs have received some support at the policy level.
Online prescription drugs were gradually liberalized
The launch of prescription drugs online has gone through twists and turns. In documents issued by the Food and Drug Administration in November 2017 and February 2018, it was mentioned that pharmaceutical retail chain companies cannot sell prescription drugs online. Immediately after April 2018, the General Office of the State Council issued the “Opinions on the Promotion of the Development of” Internet + Medical Health “”, and online sales of prescription drugs began to slacken. For the first time, the revised Drug Administration Act in 2019 removed the provision that prescription drugs must not be sold online.
The enactment of the “Opinions” further regulates online sales of prescription drugs, which certainly presents both opportunities and challenges for traditional pharmacies and Internet medical companies. Pharmacy chains themselves are qualified to sell prescription drugs and have a great location advantage compared to pharmaceutical e-commerce. Compared to pharmaceutical e-commerce, they have better offline services and higher timeliness. The pharmaceutical e-commerce business has the advantages of a ready-to-use network platform and cost control, and can make progress from online inquiries, chronic disease drugs, and long-term drug purchases.
Health insurance payment “Internet +” landed
Internet medical services usher in a golden period of development
People are more concerned about paying for health insurance online. Recently, related documents have also been published. In early November, the National Health Security Administration issued guidelines to actively advance the payment of health insurance for “Internet +” medical services. Opinions mentioned that localities can start with outpatients for chronic diseases and gradually expand health insurance coverage for common and chronic diseases. The scope of payment for the service, thus encouraging the completion of follow-up visits for mild and chronic diseases on the Internet medical platform.
Ping An Securities believes that the “Opinions” encourage and emphasize the two sectors of online diagnosis and treatment and online drug sales. Internet medical services, as a new format and a new driving force in the medical services industry, will help promote reform on the medical supply side and expand the supply of high-quality medical services. The promulgation of the “Opinions” further clarified the health insurance payment policy and online health care monitoring strategy.
Catalyzed by various policies, Internet healthcare has gradually matured since its inception and the industry has entered a critical stage of rapid development. Take, for example, the leading company Ali Health. Its monthly active users have risen rapidly from 82,000 in February 2018 to 340,000 at the end of the first half of 2020, an increase of more than 300%, and revenue from 2.2 billion yuan in fiscal year 2018 to 8.1 billion yuan in fiscal year 2020 is a 2.7-fold increase.
According to the Frost & Sullivan report, the scale of China’s online retail pharmacy market reached 105 billion yuan in 2019 and is expected to grow to 1.2 trillion yuan in 2030. The outflow of prescription drugs and the rapid development of the out-of-hospital retail market have a significant catalytic effect on the industry. After the policy is gradually implemented, the Internet medical market has huge growth potential.
Internet medicine-related actions are expected to benefit
According to the statistics of Securities Times Databao, among the companies listed in A shares, there are 66 biomedical, computing and communications companies involved in medical treatments over the Internet, involving multiple addresses such as medical electronic commerce, medical computerization, health platform and diagnosis remote of digital cases. .
Concept stocks performed well in all three quarterly reports: There were 18 companies whose parent net income increased by more than 20% and white horse stocks with a market value of more than 100 billion.Ophthalmology Aier, Fuxing Medicine is also among them.There are 7 animals with an increase of more than 100%, among the firstKangtai Medicine、Yangpu Medical、Jiu’an Medical, The increase was 1208.92%, 805.75% and 556.03% respectively.
The third quarterly report of the new stock Kangtai Medical showed that it achieved a net profit of 515 million yuan attributable to the parent company, a year-on-year increase of 1208.92%. The epidemic needs to make infrared thermometers, blood oxygen and other products sell well. The company stated in the prospectus that the company has built a SaaS telemedicine platform through its mastered telemedicine technology to provide health management services and provide remote diagnostic services for primary medical institutions.
Disclaimer: All content of the Databank information does not constitute investment advice. The stock market is risky and investing must be cautious.
Sina Statement: This news is a reprint by Sina Cooperative Media. Posting this article on Sina.com for the purpose of conveying more information does not mean that I agree with their views or confirm their description. The content of the article is for reference only and does not constitute investment advice. Investors trade accordingly at their own risk.
Massive information, accurate interpretation, all in the Sina Finance APP
Editor in charge: Chen Zhijie
